Market Cap (In PLN)
153.38 Million
Revenue (In PLN)
151.67 Million
Net Income (In PLN)
41.26 Million
Avg. Volume
46.06 Thousand
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.48-21.18
- PE
- -
- EPS
- -
- Beta Value
- 0.995
- ISIN
- PLMBION00016
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Krzysztof Kaczmarczyk
- Employee Count
- -
- Website
- https://www.mabion.eu
- Ipo Date
- 2010-08-10
- Details
- Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.
More Stocks
-
GRID
-
NICO
-
DGMLFDe Grey Mining Limited
DGMLF
-
9726
-
GRAVITYGravity (India) Limited
GRAVITY
-
HOLOWMicroCloud Hologram Inc.
HOLOW
-
TBMC
-
REMLIFEREMEDIUM LIFECARE LIMITED
REMLIFE